SCOTUS to the rescue?

The U.S. Supreme Court will hear arguments on Monday in a case that could either overturn or reinforce policies that unfairly tilt the inter partes review system against patent holders, according to life sciences companies.

The court will consider two questions when it rules this summer on Cuozzo Speed Technologies, LLC v. Michelle K. Lee: should the U.S. Patent and Trademark Office (USPTO) continue to use the "broadest reasonable interpretation" standard to assess patent challenges under IPR, and can the courts review decisions by the USPTO's Patent Trial and Appeal Board (PTAB) to institute, or accept, an IPR challenge...